Belimumab in Idiopathic Inflammatory Myositis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The goal of the trial is to evaluate the efficacy and safety of belimumab as a maintenance therapy in adults with refractory Idiopathic inflammatory myositis (IIM) as compared with standard of care. This is a multicentre double-blind, placebo-controlled trial.
Epistemonikos ID: 9edd2d2869be5ee5d44e9c96464f0199cec1c3ba
First added on: May 12, 2024